SecBot SecBot
144 ·Filed Oct 22, 2026

KRSA

Korsana Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5d 7h ago SEC0001950047-26-010364
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is de minimis and routine for a director. No material read-through — monitor for any larger insider sales or changes in beneficial ownership filings.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+1d
KRSA ▲ +2.49% at T+1d
NEUTRAL call +2.49% · α vs SPY +1.78% · entry $31.31 → $32.09
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
+2.49%
call +2.49% · α +1.78%
$32.09
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Director Michael J. Higgins filed a Form 144 notice of intent to sell 1,107 shares of Korsana Biosciences common stock, valued at approximately $35,424 based on the filing date price. This is a small, routine sale by a director and carries minimal signal value.

Key Facts

  • Filer: Director Michael J. Higgins
  • Shares to be sold: 1,107 shares of common stock
  • Estimated value: ~$35,424 (based on filing date price of ~$32.00/share)
  • Shares acquired via restricted stock vesting (11/30/2023 – 06/01/2026)
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Filing date: October 22, 2026

Financial Impact

Proposed sale of 1,107 shares worth ~$35,424 — immaterial relative to market cap and insider holdings

dilution

Risk Factors

  • Form 144 is only an intent to sell; the sale may not be executed
  • Small director sales typically carry no signal value

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010364
Document: 0001950047-26-010364-index.html0001950047-26-010364
Document: 0001950047-26-010364.txt0001950047-26-010364
8 reports for KRSA
Performance horizon
Filters
Rows
Reports for KRSA — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
144
NEUTRAL ★ 2/10
$31.31awaiting T+20—$30.07 (−3.96%)
Oct 15, 2026
12d ago
SC 13G/A
NEUTRAL ★ 2/10
$32.38awaiting T+20—$30.07 (−7.13%)
Oct 15, 2026
12d ago
DEF 14A
NEUTRAL ★ 5/10
$32.38awaiting T+20—$30.07 (−7.13%)
Sep 23, 2026
4w ago
144
NEUTRAL ★ 2/10
$37.19 $33.43▼ −10.11%▼ −9.69%$30.07 (−19.14%)
Sep 22, 2026
5w ago
144
NEUTRAL ★ 1/10
$32.30 $32.54▲ +0.74%▲ +0.06%$30.07 (−6.90%)
Sep 18, 2026
5w ago
SC 13G
NEUTRAL ★ 4/10
$33.21 $31.41▼ −5.42%▼ −4.51%$30.07 (−9.45%)
Sep 18, 2026
5w ago
144
NEUTRAL ★ 2/10
$33.21 $31.41▼ −5.42%▼ −4.51%$30.07 (−9.45%)
Sep 16, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$31.23 $34.32▲ +9.89%▲ +7.83%$30.07 (−3.71%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (9h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026